Sign in

CIK 0001783183 · Non-accelerated filer<br>Smaller reporting company

Phathom Pharmaceuticals, Inc.

Sign in to watch
Ticker
PHAT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
824151574
Phone
(877) 742-8466
Business address
100 CAMPUS DRIVE,, SUITE 102, FLORHAM PARK, NJ, 07932
  1. 4 Open-market sale 10% owner sold 20,116 shares at an average $35.96 ($723,434)
  2. 4 Open-market sale 10% owner sold 20,811 shares at an average $36.84 ($766,700)
  3. 4 Open-market sale 10% owner sold 21,541 shares at an average $35.93 ($773,889)
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Open-market sale 10% owner sold 18,746 shares at an average $35.50 ($665,439)
  11. 4 Open-market sale Director sold 40,000 shares at an average $32.64 ($1,305,506)
  12. 4 Open-market sale 10% owner sold 100 shares at $35.00 ($3,500)
  13. 4 Open-market sale 10% owner sold 11,876 shares at an average $35.44 ($420,892)
  14. 4 Open-market sale 10% owner sold 1,011 shares at $35.03 ($35,415)
  15. 4 Open-market sale 10% owner sold 7,138 shares at an average $35.14 ($250,803)
  16. 4 Open-market sale 10% owner sold 33,992 shares at an average $37.00 ($1,257,849)
  17. 4 Open-market sale Chief Operating Officer sold 14,500 shares at an average $37.84 ($548,656)
  18. 4 Open-market sale Director sold 40,000 shares at an average $36.55 ($1,462,089)
  19. 4 Open-market sale Chief Operating Officer sold 14,500 shares at an average $36.63 ($531,102)
  20. 4 Open-market sale President and Chief Executive sold 11,513 shares at an average $43.32 ($498,751)

Page 9 of 12 · 224 filings